Biblio

Journal Article
Liu S, Niu S, Li Y, Xiong H, Li Y, Jian L, Zhang L. Establishment of an induced pluripotent stem cell line (ZZUSAHi002-A) derived from peripheral blood mononuclear cells of a healthy individual. Stem Cell Res. 2020;48:101966.
Sun Y, Zhou J, Wang H, Wang H, Chen X, Gong T, Liang P, Jiang C. Establishment of an induced pluripotent stem cell line (ZJULLi004-A) from a hypertrophic cardiomyopathy patient carrying MYBPC3/c.3764C>A mutation. Stem Cell Res. 2022;64:102898.
Guo Y, Wang J, Wang ZL, Lou Y, Chen W, Sheng M, Wang Y, Zhang B, Gao L, Feng J. Establishment of an induced pluripotent stem cell line (ZJSHi001-A) from a patient with epileptic encephalopathy carrying KCNB1 Glu330Asp mutation. Stem Cell Res. 2021;52:102224.
Chen H, Ding Y, Zhou W, Li J, Qian W, Zhang Z, Li C, Tong H, Rong X, Chu M, et al. Establishment of an induced pluripotent stem cell line (WMUi016-A) from a patient with X-linked Dent disease (X-Dent) carrying the hemizygote mutation p.R718* (c.2152C > T) in the CLCN5 gene. Stem Cell Res. 2021;51:102209.
Li D, Hong X, Li W, Meng S, Yu H, Zhang X, Wang C, Samokhvalov IM, Liu D, Tang D, et al. Establishment of an induced pluripotent stem cell line SPHi001-A from a systemic lupus erythematosus patient combined with preeclampsia and psoriasis. Stem Cell Res. 2021;51:102192.
Hu J, Lu C, Zhu W, Jiang Q, Du W, Wu N. Establishment of an induced pluripotent stem cell line (SHFDi001-A) from a patient with ankylosing spondylitis. Stem Cell Res. 2020;46:101879.
Xi Y, Zhang H, Wang B, Song W, Liu Y. Establishment of an induced pluripotent stem cell line SDQLCHi049-A from a healthy male neonate. Stem Cell Res. 2023;69:103097.
Feng Z, Yang X, Guan J, Song W, Liu Y. Establishment of an induced pluripotent stem cell line SDQLCHi048-A from a healthy boy donor. Stem Cell Res. 2023;69:103115.
Wang L, Zeng Q, Wang S, Wu D, Wang J, Zhang H, Lv X. Establishment of an induced pluripotent stem cell line (SDCHi001-A) from a healthy Chinese child donor. Stem Cell Res. 2023;74:103278.
Xu M, Wang L, Yin J, Xiong J, Guo Q, Yang W. Establishment of an induced pluripotent stem cell line (SAHGMUi001-A) from a patient with Netherton syndrome carrying SPINK5 mutation. Stem Cell Res. 2021;51:102213.
He S, Jin Y, Tian Z, Hua TR, Xing HP, Zhuang SS, He XY, Li HY, Wang L, Zhang SY. Establishment of an induced pluripotent stem cell line PUMCHi004-A from a hereditary transthyretin amyloid cardiomyopathy patient with transthyretin (TTR) p.Asp38Asn mutation. Stem Cell Res. 2020;49:102022.
Hu L, Wang G, Wu H, Fu H, Wang Y, Yu F, Liu Z, Mao J. Establishment of an induced pluripotent stem cell line (NCKDi003-A) from a patient with X-linked Dent disease (X-Dent) carrying the hemizygote mutation p. T277P (c. 829A > C) in the CLCN5 gene. Stem Cell Res. 2021;56:102538.
Gridina MM, Nikitina TV, Orlova PA, Minina JM, Kashevarova AA, Yakovleva YS, Lopatkina ME, Vasilyev SA, Fedotov DA, Mikhailik LI, et al. Establishment of an induced pluripotent stem cell line (ICGi025-A) from fibroblasts of a patient with 46,XY,r(8)/45,XY,-8 mosaicism. Stem Cell Res. 2020;49:102024.
Zhang X, Zhang D, Chen S-C, Lamey T, Thompson JA, McLaren T, De Roach JN, Chen FK, McLenachan S. Establishment of an induced pluripotent stem cell line from a retinitis pigmentosa patient with compound heterozygous CRB1 mutation. Stem Cell Res. 2018;31:147-151.
He S, Hu J, Zheng Z, Wang J, Chen J, Zhang C, Li L, Wang J, Chen Z, Shi H, et al. Establishment of an induced pluripotent stem cell line from a patient with CHARGE syndrome carrying a CHD7 (p.L1151Gfs*17) mutation. Stem Cell Res. 2020;45:101774.
Shan H, Ye J, Ping XHai, XinYue H, ShuYang Z. Establishment of an induced pluripotent stem cell line from a patient with hereditary transthyretin amyloidosis carrying transthyretin (TTR) mutation p.Phe53Val. Stem Cell Res. 2020;48:101940.
Guo X, Qian R, Yang L, Chen H, Ding Y, Shan X, Chen C, Ni W, Lin J, Chu M. Establishment of an induced pluripotent stem cell line from a Noonan syndrome patient with the heterozygote mutation p.S257L (c.770C > T) in RAF1 gene. Stem Cell Res. 2021;53:102281.
Guo X, Wang D, Shan X, Yang L, Ding Y, Chen H, Rong X, Chu M, Lin J, Chen C. Establishment of an induced pluripotent stem cell line from a Antley-Bixler Syndrome (ABS) patient with the homozygote mutation p.R457H (c.1370G>A) in POR gene. Stem Cell Res. 2021;52:102261.
Bai X, Yang X, Cheng Y, Chen L. Establishment of an induced pluripotent stem cell line (FDEENTi001-A) from a patient with pathological myopia. Stem Cell Res. 2018;34:101369.
Zhao H, Wang L, Wu J, Ren J, Chen Q, Luo H, Zuo X, Tang Y. Establishment of an induced pluripotent stem cell line (CSUi003-A) from fibroblasts of a healthy elderly individual. Stem Cell Res. 2021;53:102326.
Huang C-Y, Tsai Y-H, Tsai Y-C, Lu Y-C, Chan Y-H, Hsu C-J, Chiou S-H, Wu C-C, Cheng Y-F. Establishment of an induced pluripotent stem cell (iPSC) line from a 7-year-old male patient with profound hearing loss carrying c.235delC in GJB2 gene. Stem Cell Res. 2020;45:101795.
Chang J, Sun W, Zeng J, Xue Y, Zhang Y, Pan X, Zhou Y, Lai M, Bian G, Zhou Q, et al. Establishment of an in vitro system based on AGM-S3 co-culture for screening traditional herbal medicines that stimulate hematopoiesis. J Ethnopharmacol. 2019:111938.
Iguchi T, Fujimoto K, Nakamura S, Kishino H, Niino N, Mori K. Establishment of an in vitro cytotoxicity assay platform using primary monkey cardiomyocytes. Toxicol In Vitro. 2018.
Tong Y, Cheng L-Q, Li X, Yu X-P, Shu R-H, Zhang J-H, Meng Q, Qin Q-L, Tang K, Xu J-X, et al. Establishment of an immortalized cell line derived from the pupal ovary of Mythimna separata (Lepidoptera: Noctuidae) and identification of the cell source. Cell Tissue Res. 2021.
Xue Y, Liao B, Xie Y, Li S, Ma X, Sun X. Establishment of an ectodermal dysplasia related gene EDA Knockout human embryonic stem cell line (WAe001-A-22) by CRISPR-Cas9 technology. Stem Cell Res. 2018;34:101379.

Pages